{
   "parameters" : {
      "hormon" : "hormonal therapy, 0= no, 1= yes",
      "size" : "tumor size, mm",
      "meno" : "menopausal status (0= premenopausal, 1= postmenopausal)",
      "er" : "estrogen receptors (fmol/l)",
      "grade" : "tumor grade",
      "rfstime" : "recurrence free survival time; days to first of reccurence, death or last follow-up",
      "pgr" : "progesterone receptors (fmol/l)",
      "status" : "0= alive without recurrence, 1= recurrence or\ndeath",
      "nodes" : "number of positive lymph nodes",
      "age" : "age, years",
      "pid" : "patient identifier"
   },
   "reference" : "These data sets are used in the paper by Royston and Altman.\nThe Rotterdam data is used to create a fitted model, and the GBSG data for \nvalidation of the model.  The paper gives references for the data source.",
   "usage" : "gbsg\ndata(cancer, package=\"survival\")",
   "description" : "Description\nThe gbsg data set contains patient records from a 1984-1989 trial \nconducted by the German Breast Cancer Study Group (GBSG) of 720 patients\nwith node positive breast cancer; it retains the 686 patients with \ncomplete data for the prognostic variables.",
   "title" : "Breast cancer data sets used in Royston and Altman (2013)",
   "format" : "A data set with 686 observations and 11 variables."
}
